Skip to Content

Rockwell Medical Inc RMTI

Morningstar Rating
$1.62 −0.02 (1.22%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RMTI is trading at a 45% discount.
Price
$1.62
Fair Value
$6.27
Uncertainty
Extreme
1-Star Price
$98.14
5-Star Price
$9.92
Economic Moat
Vhdlb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RMTI is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.64
Day Range
$1.601.64
52-Week Range
$1.166.24
Bid/Ask
$1.62 / $1.64
Market Cap
$47.52 Mil
Volume/Avg
81,233 / 259,738

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.46
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
237

Comparables

Valuation

Metric
RMTI
MDXG
NARI
Price/Earnings (Normalized)
80.13509.24
Price/Book Value
2.247.805.89
Price/Sales
0.463.465.45
Price/Cash Flow
20.8280.84
Price/Earnings
RMTI
MDXG
NARI

Financial Strength

Metric
RMTI
MDXG
NARI
Quick Ratio
1.312.952.43
Current Ratio
1.733.573.09
Interest Coverage
−2.765.74−56.99
Quick Ratio
RMTI
MDXG
NARI

Profitability

Metric
RMTI
MDXG
NARI
Return on Assets (Normalized)
−17.02%12.48%5.07%
Return on Equity (Normalized)
−49.55%123.45%6.37%
Return on Invested Capital (Normalized)
−18.49%42.32%3.35%
Return on Assets
RMTI
MDXG
NARI
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AYqfgwvbdSvfc$77.2 Bil
MKKGY
Merck KGaA ADRShhthfxgXnxlb$75.4 Bil
HLN
Haleon PLC ADRKbgrgdmxThdz$38.1 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRVnmygjkjTwr$16.0 Bil
VTRS
Viatris IncJgyvvpdcXjry$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRZspwfxryzHxgp$12.1 Bil
CTLT
Catalent IncSphkrxzGkxphr$10.2 Bil
PRGO
Perrigo Co PLCClyttbgyjTlw$4.3 Bil
CURLF
Curaleaf Holdings IncGjwdpdvlDkwvg$4.0 Bil
PBH
Prestige Consumer Healthcare IncVynsqtnsWxkmwtx$3.6 Bil

Sponsor Center